Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Overall Survival
68%
Malignant Neoplasm
63%
Non Small Cell Lung Cancer
62%
Prostate Cancer
58%
Chemotherapy
50%
Progression Free Survival
50%
Atezolizumab
47%
Breast Cancer
42%
Immune Checkpoint Inhibitor
40%
Clinical Trial
39%
Meta-Analysis
34%
Tumor
33%
Adverse Event
30%
Cancer
30%
Clear Cell Renal Cell Carcinoma
27%
Systematic Review
24%
Quality of Life
24%
Metastatic Colorectal Cancer
24%
Colorectal Carcinoma
22%
Cancer Therapy
22%
Proton-Pump Inhibitor
22%
Randomized Controlled Trial
22%
Clinician
18%
Immunotherapy
18%
Anticarcinogen
18%
Cisplatin
18%
Preference
18%
Lung
18%
Patient-Reported Outcome
17%
Pooled Analysis
17%
Physical Activity
16%
Monoclonal Antibody Therapy
16%
Phase II Trials
16%
Nutrition
16%
Advanced Cancer
16%
Oncology
16%
Hazard Ratio
15%
Solid Malignant Neoplasm
15%
Arm
14%
Female Genital Tract Cancer
14%
Monoclonal Antibody
13%
Body Mass Index
13%
Diseases
13%
Epidermal Growth Factor Receptor
13%
Neoplasm
12%
Cancer Registry
11%
Medical Cannabis
11%
Chemoradiotherapy
11%
Alanine Aminotransferase
11%
Somatics
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Chemotherapy Regimen
51%
Atezolizumab
47%
Clinical Trial
45%
Overall Survival
41%
Prostate Cancer
38%
Progression Free Survival
36%
Adverse Event
27%
Colorectal Carcinoma
27%
Melanoma
25%
Metastatic Colorectal Cancer
24%
Randomized Controlled Trial
24%
Pharmacokinetic
24%
Epidermal Growth Factor Receptor
23%
Diseases
23%
Solid Malignant Neoplasm
22%
Non Small Cell Lung Cancer
21%
Proton Pump Inhibitor
21%
Metformin
21%
Vasculotropin
21%
Sodium Valproate
21%
Monoclonal Antibody
21%
Neoplasm
21%
Immune Checkpoint Inhibitor
20%
Breast Cancer
19%
Combination Therapy
18%
Nausea
18%
Placebo
17%
Vemurafenib
16%
Anticarcinogen
14%
Phosphotransferase Inhibitor
13%
Antitumor Activity
13%
Ovary Cancer
13%
Sorafenib
12%
Bevacizumab
12%
Temozolomide
12%
Hypertension
11%
Ipilimumab
11%
Protein P53
11%
Androgen Receptor
11%
Carcinogenesis
11%
Pazopanib
11%
Monotherapy
11%
Glioblastoma
10%
Cisplatin
10%
Phase II Trials
10%
Chemotherapy Induced Nausea and Vomiting
10%
Transitional Cell Carcinoma
10%
Pamiparib
10%
Antimicrobial Agent
10%
Nursing and Health Professions
Prostate Cancer
51%
Chemotherapy
42%
Malignant Neoplasm
41%
Accident Prevention
24%
Physical Activity
24%
Telehealth
19%
Clinical Trial
19%
Self Care
19%
Pilot Study
17%
Nutrition
16%
Efficacy
15%
Breast Cancer
14%
Economic and Social Development
14%
Education
13%
Quality of Life
13%
Adverse Event
12%
Melanoma
10%
Qualitative Study
10%
Anticarcinogen
10%
Alanine Aminotransferase
10%
Qualitative Research
10%
Multiple Cancer
10%
Health Care Personnel
10%
Artificial Intelligence
9%
Cancer Therapy
9%
Progression Free Survival
9%
Practice Guideline
8%
Chatbot
7%
Overall Survival
7%
Androgen Deprivation Therapy
7%
Healthcare Professional
7%
Digital Health
7%
Patient Care
7%
Cost Effectiveness Analysis
6%
Colorectal Carcinoma
6%
Body Mass
6%
Non Small Cell Lung Cancer
6%
Hematologic Malignancy
6%
Patient-Reported Outcome
6%
Treatment Outcome
6%
Anticancer
5%
COVID-19
5%
Hereditary Nonpolyposis Colorectal Cancer
5%
Laboratory Technique
5%
Vitamin Blood Level
5%
Decision-Making
5%
Catheter
5%
Peripherally Inserted Central Venous Catheter
5%
Muellerian Inhibiting Factor
5%
Hormone Determination
5%